3675 MARKET STREET, PHILADELPHIA, PA
CEO Steven Kelly and CSO Michael Klichinsky Terminate Employment
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Material disclosure
News, Material Contracts
Shareholder votes
Enter into Definitive Merger Agreement to Create Company Focused on Regenerative Cell Therapies for Orthopedic Diseases
Other Events
Q2
Q1
Amended Annual Report
FY 2024
Q3
FY 2023
RW
S-4/A
Prospectus Filed Pursuant to Rule 425
S-4
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Initial Statement of Beneficial Ownership
Post-Effective Amendment to Registration Statement
Correspondence
Submission Upload